These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19722060)

  • 1. Interferon-induced Parkinsonism in a patient with chronic hepatitis C.
    Almeida CM; Galvão Mde L; Ferreira PL; Braga WS
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):715-6. PubMed ID: 19722060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
    Carneros Martín JA; Fuentes Coronel A; Alvarez Delgado A; González San Martín F
    Med Clin (Barc); 2003 Mar; 120(9):359. PubMed ID: 12646118
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pegylated interferon treatment and severe thrombocytopenia].
    Rodríguez-García G; Jiménez-Macías F; Fernández-Jurado A; Domínguez-Macías A
    Med Clin (Barc); 2006 Sep; 127(8):316-7. PubMed ID: 16949021
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C.
    Sood A; Midha V; Sood N
    Indian J Gastroenterol; 2004; 23(1):28-9. PubMed ID: 15106716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].
    Maede Y; Morishita K; Iwamura K; Takayama Y; Tsukada Y; Kishino M; Shimizu T; Matsushima S; Komatsu T; Kasagi Y
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2600-2. PubMed ID: 16419601
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
    Sagir A; Wettstein M; Heintges T; Häussinger D
    Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
    [No Abstract]   [Full Text] [Related]  

  • 7. Side effects of therapy for chronic hepatitis C.
    Russo MW; Fried MW
    Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
    Sprenger R; Sagmeister M; Offner F
    Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy.
    Antonelli A; Ferri C; Fallahi P
    Nat Rev Gastroenterol Hepatol; 2009 Nov; 6(11):633-5. PubMed ID: 19881515
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.
    Kajihara M; Montagnese S; Khanna P; Amodio P; Schapira AH; Dusheiko GM; Morgan MY
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):628-31. PubMed ID: 20075741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
    Ogata H; Suzuki H; Shimizu K; Ishikawa H; Izumi N; Kurosaki M
    Jpn J Ophthalmol; 2006; 50(3):293-5. PubMed ID: 16767392
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C.
    Altınbas A; Koybasıoglu F; Aktas E; Yılmaz B; Coban S
    Inflamm Bowel Dis; 2011 Apr; 17(4):1050. PubMed ID: 20623698
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous lesions at polyethylene glycol interferon-alpha-2a inoculation site in a hepatitis C virus-infected subject.
    Montesu MA; Siddi V; Satta R; Pirodda C; Cottoni F
    Acta Derm Venereol; 2007; 87(5):433-4. PubMed ID: 17721655
    [No Abstract]   [Full Text] [Related]  

  • 15. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
    Radha Krishna Y; Itha S
    Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
    Iwasaki Y; Ikeda F; Yamamoto K
    Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
    Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
    Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute life-threatening event with peginterferon α-2b in a child with chronic hepatitis C.
    Bhat AS; Varma S; Chaturvedi MK
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):e138. PubMed ID: 22847460
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
    Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression and hepatitis C.
    Sangwaiya A; Chan J; Ash S
    Br J Hosp Med (Lond); 2007 Dec; 68(12):682. PubMed ID: 18186414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.